BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32466217)

  • 1. Genomic and Transcriptomic Characteristics According to Size of Papillary Thyroid Microcarcinoma.
    Song YS; Kang BH; Lee S; Yoo SK; Choi YS; Park J; Park DY; Lee KE; Seo JS; Park YJ
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32466217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma.
    Lee X; Gao M; Ji Y; Yu Y; Feng Y; Li Y; Zhang Y; Cheng W; Zhao W
    Ann Surg Oncol; 2009 Feb; 16(2):240-5. PubMed ID: 19034577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Animal Model Further Uncovers the Role of Mutant Braf
    Koelsch B; Theurer S; Staniszewska M; Heupel J; Koch A; Mergener S; Walk F; Fischer C; Kutritz A; Schmid KW; Kindler-Röhrborn A
    Am J Pathol; 2020 Mar; 190(3):702-710. PubMed ID: 31953036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent BRAF
    Oishi N; Kondo T; Nakazawa T; Mochizuki K; Inoue T; Kasai K; Tahara I; Yabuta T; Hirokawa M; Miyauchi A; Katoh R
    Endocr Pathol; 2017 Jun; 28(2):103-111. PubMed ID: 28176151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
    Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
    J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
    Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutational profile of papillary thyroid microcarcinoma with extensive lymph node metastasis.
    Jeon MJ; Chun SM; Lee JY; Choi KW; Kim D; Kim TY; Jang SJ; Kim WB; Shong YK; Song DE; Kim WG
    Endocrine; 2019 Apr; 64(1):130-138. PubMed ID: 30645724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classic Architecture with Multicentricity and Local Recurrence, and Absence of TERT Promoter Mutations are Correlates of BRAF (V600E) Harboring Pediatric Papillary Thyroid Carcinomas.
    Onder S; Ozturk Sari S; Yegen G; Sormaz IC; Yilmaz I; Poyrazoglu S; Sanlı Y; Giles Senyurek Y; Kapran Y; Mete O
    Endocr Pathol; 2016 Jun; 27(2):153-61. PubMed ID: 26951110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Characterization of Differentiated Thyroid Carcinoma.
    Song YS; Park YJ
    Endocrinol Metab (Seoul); 2019 Mar; 34(1):1-10. PubMed ID: 30912334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
    Landa I; Ibrahimpasic T; Boucai L; Sinha R; Knauf JA; Shah RH; Dogan S; Ricarte-Filho JC; Krishnamoorthy GP; Xu B; Schultz N; Berger MF; Sander C; Taylor BS; Ghossein R; Ganly I; Fagin JA
    J Clin Invest; 2016 Mar; 126(3):1052-66. PubMed ID: 26878173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-Exome Sequencing in Papillary Microcarcinoma: Potential Early Biomarkers of Lateral Lymph Node Metastasis.
    Kim M; Kwon CH; Jang MH; Kim JM; Kim EH; Jeon YK; Kim SS; Choi KU; Kim IJ; Park M; Kim BH
    Endocrinol Metab (Seoul); 2021 Oct; 36(5):1086-1094. PubMed ID: 34731936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome, role of BRAF(V600E), and molecular pathways in papillary thyroid microcarcinoma: is it an indolent cancer or an early stage of papillary thyroid cancer?
    Nucera C; Pontecorvi A
    Front Endocrinol (Lausanne); 2012; 3():33. PubMed ID: 22649416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.
    Costa AM; Herrero A; Fresno MF; Heymann J; Alvarez JA; Cameselle-Teijeiro J; García-Rostán G
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):618-34. PubMed ID: 18070147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans.
    Kim SY; Kim T; Kim K; Bae JS; Kim JS; Jung CK
    J Pathol Transl Med; 2020 Jul; 54(4):310-317. PubMed ID: 32527075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients.
    Jin L; Chen E; Dong S; Cai Y; Zhang X; Zhou Y; Zeng R; Yang F; Pan C; Liu Y; Wu W; Xing M; Zhang X; Wang O
    Oncotarget; 2016 Apr; 7(14):18346-55. PubMed ID: 26943032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Japanese patients with papillary thyroid carcinoma, TERT promoter mutation is associated with poor prognosis, in contrast to BRAF
    Nasirden A; Saito T; Fukumura Y; Hara K; Akaike K; Kurisaki-Arakawa A; Asahina M; Yamashita A; Tomomasa R; Hayashi T; Arakawa A; Yao T
    Virchows Arch; 2016 Dec; 469(6):687-696. PubMed ID: 27718012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Transcriptomic and Genomic Profiling of Subtypes of Follicular Variant of Papillary Thyroid Carcinoma.
    Song YS; Won JK; Yoo SK; Jung KC; Kim MJ; Kim SJ; Cho SW; Lee KE; Yi KH; Seo JS; Park YJ
    Thyroid; 2018 Nov; 28(11):1468-1478. PubMed ID: 30226444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma.
    Rossi ED; Martini M; Capodimonti S; Lombardi CP; Pontecorvi A; Vellone VG; Zannoni GF; Larocca LM; Fadda G
    Cancer Cytopathol; 2013 Jun; 121(6):291-7. PubMed ID: 23192956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological features predictive for BRAF(V600E) mutation in papillary thyroid microcarcinomas.
    Nechifor-Boilă AC; Szász EA; Descotes F; Berger N; Zahan AE; Loghin A; Ceteraş DM; Borda A
    Rom J Morphol Embryol; 2018; 59(3):747-753. PubMed ID: 30534813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma.
    Gandolfi G; Ragazzi M; Frasoldati A; Piana S; Ciarrocchi A; Sancisi V
    Eur J Endocrinol; 2015 Apr; 172(4):403-13. PubMed ID: 25583906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.